-+ 0.00%
-+ 0.00%
-+ 0.00%

OrbiMed Advisors acquires $10 million of BlossomHill Therapeutics common shares

PUBT·08/12/2026 20:44:41
Listen to the news
OrbiMed Advisors acquires $10 million of BlossomHill Therapeutics common shares
  • OrbiMed Advisors reported a higher stake in Blossomhill Therapeutics, ending with 2,714,279 shares of common stock held indirectly.
  • Position increase reflected 625,000 shares bought in the IPO at $16.
  • Holdings also rose through conversion of Series A and Series B preferred stock into 2,089,279 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blossomhill Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000784), on August 12, 2026, and is solely responsible for the information contained therein.